These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10638408)

  • 1. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
    Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
    Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
    Henker C; Bida B; Markwardt J; Schlag P
    Nuklearmedizin; 1997 Jan; 36(1):1-6. PubMed ID: 9082335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
    Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
    J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
    Maffioli L; Mascheroni L; Mongioj V; Gasparini M; Baldini MT; Seregni E; Castellani MR; Cascinelli N; Buraggi GL
    J Nucl Med; 1994 Nov; 35(11):1741-7. PubMed ID: 7965150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [123I]IBZM uptake in metastatic melanoma.
    Maffioli LS; Mascheroni L; Clemente C; Baldini M; Castellani MR
    J Nucl Biol Med (1991); 1993 Mar; 37(1):18-20. PubMed ID: 8329472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 201Tl whole-body scintigraphy in patients with malignant melanoma.
    Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Wolf H; Clausen M; Henze E
    Nucl Med Commun; 1997 Mar; 18(3):230-4. PubMed ID: 9106776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of melanoma metastases with thallium-201 scintigraphy.
    Rettenbacher L; Koller J; Kässmann H; Galvan G
    J Nucl Med; 1998 May; 39(5):798-802. PubMed ID: 9591578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body scintigraphy in melanoma patients: comparison of 99Tcm-tetrofosmin and 201Tl.
    Rettenbacher L; Koller J; Kässmann H; Forstner R; Sedlmayer F; Holzmannhofer J; Galvan G
    Nucl Med Commun; 2000 Nov; 21(11):1001-8. PubMed ID: 11192703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.
    Cachin F; Miot-Noirault E; Gillet B; Isnardi V; Labeille B; Payoux P; Meyer N; Cammilleri S; Gaudy C; Razzouk-Cadet M; Lacour JP; Granel-Brocard F; Tychyj C; Benbouzid F; Grange JD; Baulieu F; Kelly A; Merlin C; Mestas D; Gachon F; Chezal JM; Degoul F; D'Incan M
    J Nucl Med; 2014 Jan; 55(1):15-22. PubMed ID: 24263087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
    Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
    Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
    Moins N; D'Incan M; Bonafous J; Bacin F; Labarre P; Moreau MF; Mestas D; Noirault E; Chossat F; Berthommier E; Papon J; Bayle M; Souteyrand P; Madelmont JC; Veyre A
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1478-84. PubMed ID: 12397467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
    de Herder WW; Reijs AE; Kwekkeboom DJ; Hofland LJ; Nobels FR; Oei HY; Krenning EP; Lamberts SW
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):755-67. PubMed ID: 9039343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
    Sillaire-Houtmann I; Bonafous J; Veyre A; Mestas D; D'Incan M; Moins N; Kemeny JL; Chossat F; Bacin F
    J Fr Ophtalmol; 2004 Jan; 27(1):34-9. PubMed ID: 14968075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients.
    Böni R; Steinert H; Huch Böni R; Von Schulthess GK; Meyer J; Dummer R; Burg G; Westera G
    Br J Dermatol; 1997 Jul; 137(1):96-100. PubMed ID: 9274632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected detection of nodular melanoma of the skin on the scalp by I-123 IBZM brain SPECT.
    Booij J; Boot E; van Eeden S; van Amelsvoort T
    Clin Nucl Med; 2011 Feb; 36(2):148-9. PubMed ID: 21220985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of thallium-201 in the preoperative detection of breast cancer: an adjunct to mammography and ultrasonography.
    Cimitan M; Volpe R; Candiani E; Gusso G; Ruffo R; Borsatti E; Massarut S; Rossi C; Morassut S; Carbone A
    Eur J Nucl Med; 1995 Oct; 22(10):1110-7. PubMed ID: 8542893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
    Kung HF; Kasliwal R; Pan SG; Kung MP; Mach RH; Guo YZ
    J Med Chem; 1988 May; 31(5):1039-43. PubMed ID: 2966245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry of iodine-123 iodobenzamide in healthy volunteers.
    Verhoeff NP; Sokole EB; Stabin M; Hengst D; Kung HF; Van Royen EA; Janssen AG
    Eur J Nucl Med; 1993 Sep; 20(9):747-52. PubMed ID: 8223767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(2-diethylaminoethyl)-4-[123I]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical results.
    Brandau W; Kirchner B; Bartenstein P; Sciuk J; Kamanabrou D; Schober O
    Eur J Nucl Med; 1993 Mar; 20(3):238-43. PubMed ID: 8462613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiolabelled iodobenzamide for malignant melanoma staging.
    Rodot S; Darcourt J; Bussière F; Lacour JP; Migneco O; Thyss A; Michelot JM; Bonafous JF; Schneider M; Barety M
    Melanoma Res; 1994 Oct; 4(5):307-12. PubMed ID: 7858415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.